The scientific community's expectations for biomedical research exceed funding capacity. Despite national social and economic problems, funding for biomedical research is already high. Additional funds will not solve the problem entirely. The biomedical community must set priorities and allocate money accordingly. New policies for allocating funds…

Summarizes and comments on three presentations relative to the life sciences and medicine given at the October 1995 working symposium of the Project on Conflict of Interest in University-Industry Research Relationships and included in this issue. Discusses the work of medical researcher David Blumenthal, political scientist Mark Frankel, and…

Clinical trials and access to therapeutic drugs pose dilemmas for researchers, physicians, and AIDS patients. The National Institute of Allergy and Infectious Diseases, recognizing the need for greater access to drugs by a broader spectrum of the infected population, is establishing the Community Programs for Clinical Research on AIDS. (Author/MLW)

This discussion of traditional academic medicine's resistance to changes in practice, technology, and finances looks at three current problems in medical education and two in biomedical research. Solutions are proposed, based on redefinition of the relationship between universities and medical schools and expansion of the conventional narrow focus…

Three principal aspects of capital needs in biomedical research are discussed: the significant and growing need for capital; sources; and the role of federal policy. Important assumptions, questions, and possible future trends are discussed. Consolidated thinking and effort are encouraged. (MSE)